Which heparin method works best during heart ablation?
NCT ID NCT07361081
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at two methods of giving the blood thinner heparin during a procedure called atrial fibrillation ablation. The goal is to see which method keeps the blood's clotting time in a safe range more often. Researchers reviewed records of 300 patients who had the procedure between 2018 and 2020. The findings could help reduce complications like stroke or bleeding.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- heparin
- What this could lead to
- If successful, this could point to a safer, more consistent way to give heparin during heart procedures, potentially reducing stroke and bleeding risks.
- What could go wrong
- This is a small, single-center retrospective study, not a large randomized trial. Results may not apply to all patients or hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Taiwan University Hospital,
Taipei, 100, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a smartphone alert replace daily blood thinners for AF?
- Blood fat clues could flag hidden heart rhythm risk
- Can a new heart ablation technique work without x-rays?
- Which blood thinner is safer for heart patients? a Head-to-Head test
- Smartphone light sensor may spot when an irregular heartbeat fixes itself
- Can a Wrist-Worn sensor outsmart atrial fibrillation?